Adapted from Molly Graham's August 17th 2016 Grand Rounds presentation.
Treatment of acute COPD exacerbation
Acute exacerbations are characterized by sustained (48 hours or more) worsening of shortness of breath and coughing, with or without sputum. The most common cause is a viral or bacterial infection.
Peptide inflammatory marker currently being evaluated for use as a POC marker for inflammatory and infectious disease.
Evaluation of COPD exacerbations with procalcitonin can decrease antibiotic use.
A PCT <0.1ng/mL indicates patient outcomes will not be improved with antibiotics.